Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in cancer cachexia
NCT05919147Phase 2Active, not recruiting
- Sponsor
- Pennington Biomedical Research Center
- Start
- Jan 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in cancer cachexia, sponsored by Pennington Biomedical Research Center. Started Jan 2024; status: active, not recruiting.
02
Drugs
pioglitazone
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT05919147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919147.